Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Victoria Vakiener

Director at Arrowhead Pharmaceuticals, Inc. (ARWR)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $679K

Reported trades

Filed Stock Type Shares Price Value Since
Dec 23SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 2,79942,964 held (−6%) $66.63 $186K -16.1%
Dec 23SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 5,28137,683 held (−12%) $67.97 $359K -17.8%
Dec 23SEC ARWRArrowhead Pharmaceuticals, Inc. Sell Plan 1,96035,723 held (−5%) $68.39 $134K -18.3%
  • Sell

    Director Victoria Vakiener sold $186K of ARWR at $66.63 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Victoria Vakiener sold $359K of ARWR at $67.97 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Victoria Vakiener sold $134K of ARWR at $68.39 — pre-scheduled 10b5-1 plan sale.